By Barbara Stephenson Posted April 21, 2020 InCRC2020-04-212021-03-03https://cofactorgenomics.com/wp-content/uploads/2016/10/cofactor_logo_dark.pngCofactor Genomicshttps://cofactorgenomics.com/wp-content/uploads/2016/10/cofactor_logo_dark.png200px200px CRCRecent PostsTop 100 in Cancer – 2022Cofactor Genomics Opens Enrollment for Non-small Cell Lung Cancer Study of OncoPrism Predictive Diagnostic AssayPredictive diagnostics: closing the precision medicine gapCofactor Genomics Unveils New Data Showing Novel OncoPrism Diagnostic is Nearly Twice as Accurate as PD-L1 in Identifying Immunotherapy Responders